SCP-123(SCP-123) - _专利_临床

概要

基本信息

药物类型

小分子化药

别名

靶点-

作用方式-

作用机制-

治疗领域

神经系统疾病其他疾病

在研适应症-

非在研适应症

神经痛

原研机构

Louisiana State University

在研机构-

非在研机构

St. Charles Pharmaceuticals

权益机构-

最高研发阶段无进展临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 SCP-123 相关的临床结果

登录后查看更多信息

100 项与 SCP-123 相关的转化医学

登录后查看更多信息

100 项与 SCP-123 相关的专利（医药）

登录后查看更多信息

3

项与 SCP-123 相关的文献（医药）

2010-08-01·Basic & Clinical Pharmacology & Toxicology

This article has been retracted: Safety Pharmacology, Acute Toxicity and Pharmacokinetics of SCP‐123 and Acetaminophen

作者: Donna J. Millington ; Jason Obirek ; Christopher Smith ; Jean Kaufman ; Cristina Villanueva

The following article fromBasic & Clinical Pharmacology & Toxicology, ‘Safety Pharmacology, Acute Toxicity and Pharmacokinetics of SCP‐123 and Acetaminophen’ by Donna J. Millington, Cristina Villanueva, Jason Obirek, Jean Kaufman and Christopher Smith, published online on 12 April 2010 (DOI:10.1111/j.1742‐7843.2010.00562.x) in Wiley InterScience (http://www.interscience.wiley.com), has been retracted by agreement between the authors, the journal Editor in Chief, Kim Brøsen, and John Wiley and Sons A/S. The retraction has been agreed due to incorrect author affiliation.

2010-05-01·Pain Medicine3区 · 医学

SCP-123 in a CCI Rat Neuropathic Pain Model

3区 · 医学

Article

作者: Millington, Donna J ; Obirek, Jason ; Kaufman, Jean

2009-07-17·Organic Process Research & Development3区 · 化学

First Multigram Preparation of SCP-123, A Novel Water-Soluble Analgesic

3区 · 化学

Article

作者: Trudell, Mark L. ; Narducy, Kenneth W. ; Miao, Lei ; Xu, Liang

A short multi-gram process for the preparation of the analgesic compound SCP-123 (4) and its sodium salt has been developed.

100 项与 SCP-123 相关的药物交易